<DOC>
	<DOC>NCT00967187</DOC>
	<brief_summary>To evaluate the antiretroviral activity and safety of 200 mg BID and 300 mg BID doses of MPC-4326 administered as monotherapy for 14 days to HIV-1 positive patients. Patients with an initial treatment response will have the option to continue MPC-4326 in combination with an Optimized Backround Regimen for a maximum of 72 weeks.</brief_summary>
	<brief_title>Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Be at least 18 years of age at the time of screening. Have HIV1infection. Have a CD4+lymphocyte countâ‰¥100 cells/mm3 Have a screening plasma HIV1 RNA value, measured by the Roche Amplicor assay, of 2,000 500,000 copies/mL (inclusive). Be free from any acute infection or serious medical illness within 14 days prior to study entry. Current opportunistic infection characteristic of AIDS (Category C according to the CDC Classification System for HIV1 Infection, 1993 Revised Version, Appendix A) that is diagnosed within 30 days or is poorly controlled. Patients with systolic blood pressure &lt; 90 mmHg or &gt; 140 mmHg or diastolic blood pressure &lt; 60 mmHg or &gt; 90 mmHg. A history of seizures (excluding pediatric febrile seizures) or current administration of prophylactic antiseizure medications. A history of cerebrovascular accident (CVA) or transient ischemic attacks (TIA). Patients with the following laboratory parameters within 30 days prior to first dose of study drug: Hemoglobin &lt; 10.0 g/dL for men and &lt; 9.0 g/dL for women Neutrophil count &lt; 1000/mm3 Platelet count &lt; 50,000/mm3 AST or ALT &gt; 2.5 times the upper limit of normal (patients with a positive HBV surface antigen or HCV antibody test at screening must have AST and ALT no more than 1.5 times the upper limit of normal)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>